ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 118 filers reported holding ANAPTYSBIO INC in Q4 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,177,589 | -10.9% | 399,594 | +0.9% | 0.00% | 0.0% |
| Q2 2023 | $8,055,053 | -7.1% | 396,020 | -0.6% | 0.00% | 0.0% |
| Q1 2023 | $8,669,322 | +71311.2% | 398,406 | +1.7% | 0.00% | -50.0% |
| Q4 2022 | $12,140 | -99.9% | 391,764 | +6.3% | 0.00% | +100.0% |
| Q3 2022 | $9,402,000 | +24.8% | 368,599 | -0.7% | 0.00% | 0.0% |
| Q2 2022 | $7,535,000 | -14.4% | 371,224 | +4.3% | 0.00% | 0.0% |
| Q1 2022 | $8,803,000 | -33.0% | 355,838 | -5.8% | 0.00% | -50.0% |
| Q4 2021 | $13,130,000 | +34.9% | 377,860 | +5.3% | 0.00% | +100.0% |
| Q3 2021 | $9,734,000 | -2.3% | 358,932 | -6.6% | 0.00% | 0.0% |
| Q2 2021 | $9,960,000 | +17.2% | 384,142 | -2.6% | 0.00% | 0.0% |
| Q1 2021 | $8,499,000 | +10.8% | 394,415 | +10.5% | 0.00% | 0.0% |
| Q4 2020 | $7,671,000 | +38.4% | 356,814 | -5.0% | 0.00% | 0.0% |
| Q3 2020 | $5,542,000 | -29.0% | 375,757 | +7.5% | 0.00% | -50.0% |
| Q2 2020 | $7,811,000 | +54.6% | 349,650 | -2.2% | 0.00% | +100.0% |
| Q1 2020 | $5,052,000 | -55.7% | 357,587 | -49.1% | 0.00% | 0.0% |
| Q4 2019 | $11,412,000 | +2.9% | 702,384 | +121.5% | 0.00% | -66.7% |
| Q3 2019 | $11,093,000 | -37.3% | 317,046 | +1.1% | 0.00% | -25.0% |
| Q2 2019 | $17,696,000 | -12.3% | 313,656 | +13.5% | 0.00% | -20.0% |
| Q1 2019 | $20,182,000 | -37.7% | 276,278 | -45.6% | 0.01% | 0.0% |
| Q4 2018 | $32,374,000 | +38.1% | 507,516 | +116.0% | 0.01% | -28.6% |
| Q3 2018 | $23,444,000 | +104.7% | 234,989 | +45.8% | 0.01% | +75.0% |
| Q2 2018 | $11,452,000 | -26.3% | 161,216 | +8.0% | 0.00% | -20.0% |
| Q1 2018 | $15,537,000 | +6.0% | 149,285 | +2.5% | 0.01% | 0.0% |
| Q4 2017 | $14,663,000 | +427.6% | 145,590 | +83.1% | 0.01% | +400.0% |
| Q3 2017 | $2,779,000 | +104.9% | 79,516 | +40.3% | 0.00% | 0.0% |
| Q2 2017 | $1,356,000 | -10.9% | 56,672 | +3.3% | 0.00% | 0.0% |
| Q1 2017 | $1,522,000 | – | 54,865 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |